前沿论文｜CELL INTELLIGENCE

Bioengineered cell therapies for pediatric solid tumors: unmet needs and a measurement-integrated approach.

PubMed 2026/09/11 发表Prog Biomed Eng (Bristol)Q1 · IF 8.5（JCR 2025）

Depletion of an immature cord blood NK subset reverses trogocytosis-driven CAR NK dysfunction.

PubMed 2026/07/29 发表Cancer CellQ1 · IF 56.1（JCR 2025）

Dual-module aCAR-iCAR NK cells for solid tumors: cascade resistance mechanisms, AI-driven engineering, and precision stratification.

PubMed 2026/07/28 发表Front ImmunolQ1 · IF 7（JCR 2025）

The innate regenerome: Harnessing mesenchymal niches and engineered cytotoxic killers for solid tumor immunotherapy.

PubMed 2026/07/28 发表Exp Cell ResQ2 · IF 3.5（JCR 2025）

Enhancing CAR-NK persistence to unlock its full therapeutic potentials.

PubMed 2026/07/08 发表Front ImmunolQ1 · IF 7（JCR 2025）

Advances and prospects in cell therapy for cancer: explorations from T cells to stem cells.

PubMed 2026/07/01 发表Signal Transduct Target TherQ1 · IF 81.2（JCR 2025）

Advancing CAR-NK cell therapy in solid tumors: Current landscape and future directions.

PubMed 2026/06/25 发表Cell Rep MedQ1 · IF 14（JCR 2025）

Advancing engineered nanoparticles for enhanced efficacy in cancer immunotherapy: optimizing nanoparticles for cancer immunotherapy.

PubMed 2026/06/24 发表Mol Biol RepQ3 · IF 3.2（JCR 2025）

Bispecific CAR T and CAR NK cells in dual-threat immunotherapy: opportunities and challenges.

PubMed 2026/06/19 发表Mol Biol RepQ3 · IF 3.2（JCR 2025）

Next-generation CAR-NK cell therapy: engineering strategies, translational challenges, and future perspectives in cancer immunotherapy.

PubMed 2026/06/18 发表Cancer Cell IntQ1 · IF 7（JCR 2025）

前沿论文 121